NHSQueue

Newmedica - Cheshire Oaks

Independent Sector ·

www.newmedicacheshireoaks.nhs.uk

Wait Score

A

CQC Rating

Not rated

About Newmedica - Cheshire Oaks

Newmedica - Cheshire Oaks is an NHS trust in the Independent Sector region. As of the latest data, there are 557 patients on the waiting list. 86.4% of patients are seen within the 18-week NHS target.

5.6pp gap
vs 92% NHS target
#146
of 416 trusts
↘ Declining
-6.6pp (3 months)
Ophthalmology
Longest wait (557 patients)

Waiting Times Overview

Median Wait

11.5 weeks

Within 18 Weeks

86.4%

Total Waiting

557

Over 52 Weeks

0

12-Month Trend (% Within 18 Weeks)

Loading chart...

Waiting Times by Specialty

View all →
Ophthalmology(national)86.4%A
💷

Tired of waiting?

Private options near Newmedica - Cheshire Oaks

Spire Healthcare

  • Hip Replacement£8,500-£12,000
  • Cataract Surgery£2,400-£3,200

Practice Plus Group

  • Hip Replacement£7,900-£10,500
  • Hernia Repair£2,100-£3,500
Explore Private Options →

Costs are estimates. Verify with the provider directly.

Frequently Asked Questions

How long are waiting times at Newmedica - Cheshire Oaks?

As of January 2026, 86.4% of patients at Newmedica - Cheshire Oaks are seen within the NHS 18-week target. There are currently 557 patients on the waiting list.

What is the CQC rating for Newmedica - Cheshire Oaks?

Newmedica - Cheshire Oaks has not yet been individually rated by the CQC in our dataset.

Does Newmedica - Cheshire Oaks have an A&E department?

This provider does not appear to operate a Type 1 A&E department, or A&E data is not available.

How does Newmedica - Cheshire Oaks compare to other hospitals?

The national average is 61.4% of patients seen within 18 weeks. Newmedica - Cheshire Oaks performs above average at 86.4%.

Data sourced from NHS England (Referral to Treatment waiting times, A&E statistics) and Care Quality Commission (CQC ratings). Last updated: 2026-03-14.

This website is independently operated and is not affiliated with or endorsed by the NHS. Learn more about our data sources.